Importantly, as a clinical medicine for the treatment of diabetic peripheral neuropathy, clinical trials suggested that lipoic acid could reduce peripheral neuropathy pain intensity experienced by patients with type 2 diabetes mellitus and improve insulin sensitivity in prediabetic individuals (46–48). Here, INS is linked to diabetes mellitus.